skip to main content
Show Results with:

Results 1 - 10 of 34  for Everything in this catalogue

results 1 2 3 4 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Effects of coenzyme Q10 supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials

Mazidi, Mohsen; Kengne, Andre Pascal; Banach, Maciej

Pharmacological research. Volume 128 (2018); pp 130-136 -- Academic Press

Online access

2
Material Type:
Article
Add to My workspace

D-003 (Saccharum officinarum): The forgotten lipid-lowering agent

Awad, Kamal; Penson, Peter; Banach, Maciej

Pharmacological research. Volume 114 (2016, December); pp 42-46 -- Academic Press

Online access

3
Material Type:
Article
Add to My workspace

Effects of coenzyme Q10 supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials

Mazidi, Mohsen; Kengne, Andre Pascal; Banach, Maciej

Pharmacological research. Volume 128: (2018, February); pp 130-136 -- Academic Press

Online access

4
Material Type:
Article
Add to My workspace

Botanicals and phytochemicals active on cognitive decline: The clinical evidence

Cicero, Arrigo F.G.; Fogacci, Federica; Banach, Maciej

Pharmacological research. Volume 130 (2018); pp 204-212 -- Academic Press

Online access

5
Material Type:
Article
Add to My workspace

Botanicals and phytochemicals active on cognitive decline: The clinical evidence

Cicero, Arrigo F.G.; Fogacci, Federica; Banach, Maciej

Pharmacological research. Volume 130: (2018, April); pp 204-212 -- Academic Press

Online access

6
Material Type:
Article
Add to My workspace

Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry

Dyrbuś, Krzysztof et al.

Pharmacological research. Volume 132 (2018); pp 204-210 -- Academic Press

Online access

7
Material Type:
Article
Add to My workspace

Regulation of PCSK9 by nutraceuticals

Momtazi, Amir Abbas et al.

Pharmacological research. Volume 120 (2017); pp 157-169 -- Academic Press

Online access

8
Material Type:
Article
Add to My workspace

Modulation of heat shock proteins by statins

Forouzanfar, Fatemeh

Pharmacological research. Volume 134: (2018, August); pp 134-144 -- Academic Press

Online access

9
Material Type:
Article
Add to My workspace

Effects of curcumin on HDL functionality

Ganjali, Shiva et al.

Pharmacological research. Volume 119: (2017, May); pp 208-218 -- Academic Press

Online access

10
Material Type:
Article
Add to My workspace

Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19, 287 patients

Dyrbus, Krzysztof et al.

Pharmacological research. Volume 139: (2019, January); pp 460-466 -- Academic Press

Online access

Results 1 - 10 of 34  for Everything in this catalogue

results 1 2 3 4 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (26)
  2. Online: Reading Room only  (22)
  3. Purchase a copy  (12)
  4. Refine further open sub menu

Subject 

  1. Vitamin D--Adiponectin--Leptin--Meta-analysis--Systematic review  (3)
  2. HIV--Efficacy--Lipids--Safety--Statin therapy  (3)
  3. ART antiretroviral therapy--AUC24 24 h area under the concentration-time curve--BMI body mass index--CI confidence interval--CYP cytochrome--HDL-C high density lipoprotein cholesterol--HIV human immunodeficiency virus--HMG-CoA 3-hydroxy-3-methylglutaryl-CoA--ICAM-1 intracellular adhesion molecule-1--LDL low density lipoprotein--LFA1 lymphocyte function antigen-1--non-HDL-C non-high density lipoprotein cholesterol--RCT randomized controlled trial--SD standard deviation--TG triglycerides--WMD weighted mean difference  (2)
  4. Curcumin--High-density lipoprotein--Dyslipidemia--Atherosclerosis--Cholesterol efflux  (2)
  5. Hyperlipidaemia--Coronary artery disease--Secondary prevention--Statins  (2)
  6. Fibrates--Glucose--Insulin--Insulin resistance--Meta-analysis  (2)
  7. Safety--Red yeast rice--Musculoskeletal disorders--Non-musculoskeletal adverse events--Serious adverse events  (2)
  8. Hyperlipidaemia--Acute coronary syndrome--Secondary prevention--Statins--LDL-C target--Intensive statin treatment  (2)
  9. Statin--Heat shock proteins--HMG-CoA--Atherogenesis  (2)
  10. Alzheimer's disease--Botanicals--Cognitive impairment--Humans--Nutraceuticals--Phytochemicals  (2)
  11. Meta-analysis--Coenzyme Q10--C-reactive protein  (2)
  12. Antithrombin III--Fibrinogen--Postmenopausal women--Tibolone  (2)
  13. Familial hypercholesterolemia--Low-density lipoprotein receptor--Atherosclerosis--Coronary heart disease--Gene therapy--Stem cell therapy  (2)
  14. ALA alpha-linolenic acid--ApoB apolipoprotein B--ApoER2 apolipoprotein E receptor2--APMF aqueous extract of PM fruit  (1)
  15. Blood pressure--Cholesterol--Dyslipidemia--Hypertension--Lipids--Renal disease--Statin intolerance statin myopathy  (1)
  16. 2VO--ABCA1--ABCG1--AGE--AIM-HIGH--ANXA1--AP-1--Apo-AI--Apo--ARE--cAMP--CD36--CE--CREBP--CETP--CE/TG--CEC--CREB--CVD--DSS--EF24--FAO/WHO--FC--FDA--FN--GMC--HDL-C--HFD--HFO--HMGA2--HO-1--HPS2- THRIVE--I/R--ILLUMINATE--IDL--LCAT--JECFA--LDL--LDLR--LFO--LXRα--MiR--MPO--NC--NAFLD--NFBκF--Nrf2--OxLDL--PKA--PL--PKA--PLTP--PON1--PPARγ--RCT--ROS--RXR--SAA--S1P--SIRT1--SphK1--SR-A--SR-BI--TC--TG--UPS--UTR--VaD--VLDL--Wt--XIAP  (1)
  17. ATP Adult treatment panel--BMI Body mass index--BP Blood pressure--CAD Coronary artery disease--CHD Coronary heart disease--CK Creatine kinase--CMA Comprehensive Meta-Analysis--Cr Creatinine--CV Cardiovascular--CVD Cardiovascular disease--CI Confidence interval--FMD Flow-mediated dilation--FSGS Focal segmental glomerulosclerosis--GCP Good clinical practice--H High risk of bias--HDL-C High-density lipoprotein cholesterol--HMG-CoA 3-hydroxy-3-methyl-glutaryl-CoA--ILEP International Lipid Expert Panel--IRB Institutional Review Board--L Low risk of bias--LDL-C Low-density lipoprotein cholesterol--MPGN Membranoproliferative glomerulonephritis--MuD Musculoskeletal disorders--Non-MuD Non-musculoskeletal adverse events--NA Not available--OR Odds-ratios--PWV Pulse wave velocity--RCTs Randomized controlled clinical trials--RYR Red yeast rice--SAE Serious adverse events--SAMS Statin-associated muscle symptoms--SAMS-CI SAMS clinical index--SD Standard deviation--TC Total cholesterol--TG Triglycerides--U Unclear risk of bias--ULN Upper limit of normal--USA United States of America  (1)
  18. Refine further open sub menu

Creation date 

From To

Searching Remote Databases, Please Wait